
Decrypt·Jose Antonio Lanz·2h ago
OpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt Work
Read original on DecryptThe ChatGPT maker is folding Orchestra’s drug-program agents into Rosalind, its life sciences suite, betting AI can shave time off the decade-plus it takes to bring a medicine to patients.
Discussion · 0
Reply with your take — replies appear on this article and in the main feed. Open thread
